Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Uniqure NV - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
QURE
Nasdaq
8731
http://www.uniqure.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Uniqure NV
13 Best Biotech Stocks To Buy Under $20
- Mar 13th, 2024 11:07 am
uniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Have Been Cutting Their Estimates
- Mar 3rd, 2024 12:00 pm
uniQure NV CEO Matthew Kapusta Sells 27,904 Shares
- Feb 29th, 2024 2:06 pm
uniQure NV (QURE) Reports 2023 Financial Results Amid Strategic Reorganization
- Feb 28th, 2024 1:35 pm
UniQure (QURE) Reports Q4 Loss, Tops Revenue Estimates
- Feb 28th, 2024 1:20 pm
uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
- Feb 28th, 2024 12:05 pm
12 Best Medical Stocks to Buy Under $10
- Feb 27th, 2024 8:30 am
Investors still aren’t sold on UniQure’s gene therapy for Huntington’s
- Dec 19th, 2023 12:15 pm
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
- Dec 19th, 2023 12:05 pm
CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in People Living with Hemophilia B
- Dec 12th, 2023 12:30 am
12 Best Genomics Stocks To Buy Now
- Dec 10th, 2023 4:59 pm
uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Dec 8th, 2023 12:05 pm
Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago
- Dec 2nd, 2023 12:24 pm
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease
- Nov 29th, 2023 12:05 pm
3 Micro-Cap Stocks That Could Be Moonshots
- Nov 15th, 2023 3:31 am
Calculating The Fair Value Of uniQure N.V. (NASDAQ:QURE)
- Nov 11th, 2023 1:43 pm
Wall Street Analysts Believe uniQure (QURE) Could Rally 405.37%: Here's is How to Trade
- Nov 8th, 2023 2:55 pm
UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates
- Nov 7th, 2023 1:25 pm
uniQure NV (QURE) Reports Q3 2023 Earnings: Net Loss Widens, Cash Position Strengthens
- Nov 7th, 2023 1:12 pm
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
- Nov 7th, 2023 12:05 pm
Scroll